Neurobehavioral & Cognitive Disorders
Neglect
Dec. 11, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Radiation isodose lines for 20-year-old male treated with craniospinal proton radiotherapy and pineal region boost without chemotherapy for pineal germinoma with leptomeningeal metastases. (A) Isodose lines depicting dose of 23.4 Gy (pink) to the whole brain and boost to 45 Gy (white) to pineal disease. Isodose curves show steep falloff between 23.4 Gy CSI dose and 45 Gy primary tumor boost. (B) Sagittal CT of colorwash representation of radiation doses for craniospinal radiation. Target is covered by 23.4 Gy (red). Note steep dose fall-off in midvertebral body and lack of exit dose in abdomen with proton radiotherapy. (Contributed by Dr. Nadia Laack.)